Efficiency of ADOPTIVE immunotherapy for melanoma: a case REPORT

Efficiency of ADOPTIVE immunotherapy for melanoma: a case REPORT

A lot of research is focused on finding better treatment options for cancer. Along with radical treatment, cancer immunotherapy has proved to be useful for a growing number of cancer patients. We report a case of stage IIIB melanoma in a 53-year woman who received adoptive immunotherapy with cytokin...

Descripció completa

Dades bibliogràfiques
Autors principals:	E. V. Abakushina, I. A. Pasova, Yu. V. Marizina, D. V. Kudryavtsev, G. T. Kudryavtseva, E. S. Fomina
Format:	Article
Idioma:	Russian
Publicat:	Russian Academy of Sciences, Tomsk National Research Medical Center 2016-11-01
Col·lecció:	Сибирский онкологический журнал
Matèries:	melanoma adoptive immunotherapy cytokine-induced killer cells markers of lymphocyte activation adoptive immunotherapy effectiveness
Accés en línia:	https://www.siboncoj.ru/jour/article/view/411

Ítems similars

LYMPHOCYTE PHENOTYPE IN PATIENTS WITH SKIN MELANOMA AFTER IMMUNOTHERAPY OF ACTIVATED LYMPHOCYTES
per: E. V. Abakushina, et al.
Publicat: (2015-01-01)

LYMPHOCYTE SUBPOPULATIONS IN GASTRIC AND COLORECTAL CANCER PATIENTS AFTER IMMUNOTHERAPY WITH ACTIVATED LYMPHOCYTES
per: E. V. Abakushina, et al.
Publicat: (2014-11-01)

Natural Killer cell recognition of melanoma: new clues for a more effective immunotherapy
per: Raquel eTarazona, et al.
Publicat: (2016-01-01)

ADOPTIVE CELL THERAPY: CURRENT ADVANCES
per: T. V. Shamova, et al.
Publicat: (2020-03-01)

Researche Advances on CIK Cells and Their Clinical Use in Lung Cancer
per: Hu LUO, et al.
Publicat: (2011-12-01)

Co-transfer of tumor-specific effector and memory CD8+ T cells enhances the efficacy of adoptive melanoma immunotherapy in a mouse model
per: Amanda Contreras, et al.
Publicat: (2018-05-01)

Limited Clinical Efficacy with Potential Adverse Events in a Pilot Study of Autologous Adoptive Cell Therapy in Canine Oral Malignant Melanoma
per: Yuan-Yuan Xia, et al.
Publicat: (2024-03-01)

Impaired T cell proliferation by ex vivo BET-inhibition impedes adoptive immunotherapy in a murine melanoma model
per: Jonathan Chee, et al.
Publicat: (2020-02-01)

Combination of Ipilimumab and Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes for Patients with Metastatic Melanoma
per: John E. Mullinax, et al.
Publicat: (2018-03-01)

Adoptive transfer of tumor-infiltrating lymphocytes in melanoma: a viable treatment option
per: Maartje W. Rohaan, et al.
Publicat: (2018-10-01)

Efficacy of Cytokine-Induced Killer Cell Immunotherapy for Patients With Pathologically Pure Glioblastoma
per: Myung-Hoon Han, et al.
Publicat: (2022-04-01)

Cancer Immunotherapy Based on Natural Killer Cells: Current Progress and New Opportunities
per: Weilei Hu, et al.
Publicat: (2019-05-01)

CHARACTERISTICS OF LYMPHOCYTE SUBPOPULATION COMPOSITION IN CANCER PATIENTS UNDERGOING COMBINED MODALITY TREATMENT INCLUDING ADAPTIVE IMMUNOTHERAPY
per: E. V. Abakushina, et al.
Publicat: (2016-02-01)

Immersion in the search for effective cancer immunotherapies
per: Steven A. Rosenberg
Publicat: (2021-06-01)

NIVO-TIL: combination anti-PD-1 therapy and adoptive T-cell transfer in untreated metastatic melanoma: an exploratory open-label phase I trial
per: Jean-Matthieu L'Orphelin, et al.
Publicat: (2024-11-01)

Combining immunotherapy with oncogene-targeted therapy: a new road for melanoma treatment
per: Mariana eAris, et al.
Publicat: (2015-02-01)

Comparative assessment of autologous and allogeneic iNKT cell transfer in iNKT cell-based immunotherapy
per: Mariko Takami, et al.
Publicat: (2024-08-01)

Clinical Applications of Combined Immunotherapy Approaches in Gastrointestinal Cancer: A Case-Based Review
per: Yesim Eralp, et al.
Publicat: (2023-09-01)

Technical advances in NK cell-based cellular immunotherapy
per: Fang Fang, et al.
Publicat: (2019-12-01)

Th17 Cells Paradoxical Roles in Melanoma and Potential Application in Immunotherapy
per: Chen Chen, et al.
Publicat: (2019-02-01)

Cytokine Induced Killer (CIK) Cells Based Adoptive Immunotherapy
per: S Timalsena, et al.
Publicat: (2018-08-01)

Adoptive Immunotherapy for Prophylaxis and Treatment of Cytomegalovirus Infection
per: Christopher P. Ouellette
Publicat: (2022-10-01)

Adoptive chimeric antigen receptor T cell (CAR-T) and Treg cell-based immunotherapies: Frontier therapeutic aspects in cancers
per: Mehran Bahraini, et al.
Publicat: (2021-11-01)

Cytokine-induced memory-like natural killer cells for cancer immunotherapy
per: Mubin Tarannum, et al.
Publicat: (2021-12-01)

Adoptive T Cell Immunotherapy for Cancer
per: Karlo Perica, et al.
Publicat: (2015-01-01)

Activity-regulated cytoskeleton-associated protein/activity-regulated gene 3.1 (Arc/Arg3.1) enhances dendritic cell vaccination in experimental melanoma
per: Xin-Wen Zhang, et al.
Publicat: (2021-01-01)

Ex vivo enrichment of PRAME antigen‐specific T cells for adoptive immunotherapy using CD137 activation marker selection
per: Koon H Lee, et al.
Publicat: (2020-01-01)

Immunotherapy in melanoma: advances, pitfalls, and future perspectives
per: Cristina Sorino, et al.
Publicat: (2024-06-01)

Challenges to the broad application of allogeneic natural killer cell immunotherapy of cancer
per: Philippa R. Kennedy, et al.
Publicat: (2022-04-01)

Research progress of adoptive cell therapy in malignant glioma
per: Meng LI
Publicat: (2016-02-01)

NK Cell-Based Immunotherapy and Therapeutic Perspective in Gliomas
per: Changqing Pan, et al.
Publicat: (2021-10-01)

Long‐term (>5‐year) survivors among unresectable or metastatic cancer patients treated with zoledronate‐activated killer cells: Seven case reports
per: Yoshiyuki Yamaguchi
Publicat: (2022-11-01)

Radiotherapy enhances natural killer cell cytotoxicity and localization in pre-clinical canine sarcomas and first-in-dog clinical trial
per: Robert J. Canter, et al.
Publicat: (2017-12-01)

PD-1 expression on tumor-specific T cells: Friend or foe for immunotherapy?
per: Sylvain Simon, et al.
Publicat: (2018-01-01)

Cytotoxicity of WT1-reactive T cells against Wilms tumor: An implication for antigen-specific adoptive immunotherapy
per: Seyed Mostafa Monzavi, et al.
Publicat: (2023-09-01)

The Advantages and Challenges of Anticancer Dendritic Cell Vaccines and NK Cells in Adoptive Cell Immunotherapy
per: Elena V. Abakushina, et al.
Publicat: (2021-11-01)

Adoptive cell transfer: new perspective treatment in veterinary oncology
per: Joanna Katarzyna Bujak, et al.
Publicat: (2018-10-01)

New Orders to an Old Soldier: Optimizing NK Cells for Adoptive Immunotherapy in Hematology
per: Mehmet Gunduz, et al.
Publicat: (2021-09-01)

Tumor-infiltrating lymphocytes in melanoma: from prognostic assessment to therapeutic applications
per: Meshack Bida, et al.
Publicat: (2024-12-01)

Natural killer cells modified with a Gpc3 aptamer enhance adoptive immunotherapy for hepatocellular carcinoma
per: Youshi Zheng, et al.
Publicat: (2023-09-01)